Form 4: Ventyx Biosciences CEO Sells Shares for Tax Obligations
Insider Transaction Report
Ventyx Biosciences CEO Raju Mohan sold 47,345 shares of common stock to cover tax withholding obligations after 116,668 restricted stock units vested.
Summary
- Raju Mohan, CEO and President of Ventyx Biosciences, Inc. (VTYX), reported changes in beneficial ownership.
- On December 17, 2025, 116,668 Restricted Stock Units (RSUs) vested, converting into 116,668 shares of Ventyx Biosciences, Inc. common stock at an exercise price of $0.
- Following this vesting, Mohan's direct beneficial ownership of common stock was 2,420,208 shares.
- On December 18, 2025, Mohan sold 47,345 shares of common stock at a weighted average price of $7.7191 per share.
- The sale was a broker-assisted transaction specifically to satisfy tax withholding obligations related to the RSU vesting.
- The shares were sold within a price range of $7.595 to $7.85.
- After the sale, Mohan's direct beneficial ownership of common stock decreased to 2,372,863 shares.
- The RSUs vest over four years, with 25% vesting on the one-year anniversary of the Vesting Commencement Date (December 17, 2021) and 25% on each of the next three anniversaries.
Sentiment
Score: 5
Explanation: The transaction is a routine insider sale to cover tax obligations upon RSU vesting, which is a common occurrence and generally not indicative of a change in management's confidence in the company.
Positives
- Vesting of 116,668 Restricted Stock Units (RSUs) for CEO Raju Mohan, indicating compensation realization.
Negatives
- Sale of 47,345 shares of common stock by the CEO, which, while for tax purposes, reduces insider ownership.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitors.
Stakeholder Impact
- Shareholders: May observe a slight decrease in insider ownership, but the reason (tax withholding) mitigates negative interpretation.
Key Dates
| Date | Description |
|---|---|
| 12/17/2021 | Vesting Commencement Date for Restricted Stock Units. |
| 12/17/2025 | 116,668 Restricted Stock Units (RSUs) vested, converting into common stock. |
| 12/18/2025 | Sale of 47,345 shares of common stock by CEO Raju Mohan. |
| 12/19/2025 | Date the Form 4 was signed and filed. |
Keywords
Ventyx Biosciences, VTYX, Raju Mohan, Form 4, insider transaction, stock sale, RSU vesting, beneficial ownership, CEO, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.